RSV Vaccine May Be On Market In 2023, CDC’s ACIP Anticipates

 
• By Brenda Sandburg
  
Respiratory syncytial virus
CDC advisory committee plans to review five RSV vaccines in the next year • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA Performance Tracker

More from Regulatory Trackers